View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
January 7, 2014

Florida hospital offers Boston Scientific’s implantable defibrillator for at-risk heart patients

Florida Hospital Tampa, a not-for-profit 475-bed tertiary hospital, has announced the successful implantation of the new subcutaneous implantable defibrillator (S-ICD) system from Boston Scientific in two patients who are at risk of sudden cardiac arrest (SCA), at its Florida Hospital Pepin Heart Institute.

tampa

Florida Hospital Tampa, a not-for-profit 475-bed tertiary hospital, has announced the successful implantation of the new subcutaneous implantable defibrillator (S-ICD) system from Boston Scientific in two patients who are at risk of sudden cardiac arrest (SCA), at its Florida Hospital Pepin Heart Institute.

Florida Hospital Pepin Heart Institute, located at Florida Hospital Tampa, is reportedly the first in Tampa Bay to offer the S-ICD system defibrillator for patients at risk of SCA.

The S-ICD system is implanted just below the skin without the need for thin, insulated wires – known as leads – to be placed into the heart itself. This leaves the heart and blood vessels untouched.

The product is a new alternative to traditional ICDs for the treatment of life-threatening ventricular arrhythmias.

Florida Hospital Pepin Heart Institute Electrophysiology Lab medical director Dr Yamamura said that, for many years, implantable defibrillators have saved lives, but the leads used in traditional defibrillators can be problematic.

"Some leads have been recalled and we’ve had to remove them. Now, with the S-ICD system there are no leads inside the heart and the long-term risk for infection is lower," Dr Yamamura added.

"With the S-ICD system there are no leads inside the heart and the long-term risk for infection is lower."

"This is yet another first for Florida Hospital Pepin Heart Institute and an exciting new technology for select patients at risk for SCA. We successfully performed the procedure on two patients on Monday, December 23rd. Both patients are doing well."

The S-ICD system consists of a pulse generator, which powers the system, monitors heart activity and delivers a shock whenever it is required. It also has an electrode that enables the device to sense the cardiac rhythm and serves as a pathway for shock delivery when necessary.

The two components are implanted under the skin – the generator at the side of the chest and the electrode beside the breastbone.

The S-ICD system can be implanted using only anatomical landmarks, which eliminates the need for fluoroscopy during implant.

The S-ICD system, which obtained FDA approval in September 2012, is commercially available in many countries in Europe as well as New Zealand.

Florida Hospital Tampa offers cardiovascular medicine, neuroscience, orthopaedics, women’s services, paediatrics, oncology, endocrinology, bariatrics, wound healing, sleep medicine and general surgery including minimally invasive and robotic-assisted procedures.


Image: Florida Hospital Tampa. Photo courtesy of Florida Hospital Tampa/PRWEB.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management